The path to curing degenerative eye diseases: Introducing the case study of "Freedom EVO."
The Australian Centre for Eye Research (CERA), established in 1996, is an institution that combines public health and clinical epidemiology with cutting-edge research to elucidate the causes of eye diseases and develop new treatments. The Neuroregeneration Research Unit and the Clinical Genetics Unit are creating cell models of diseases that can lead to blindness, such as glaucoma, age-related macular degeneration (AMD), and hereditary retinal dystrophies, using induced pluripotent stem cells (iPS cells) to explore potential therapies. After establishing stem cell lines, the challenge was to develop a reliable protocol for maintaining this cell culture, but the manual process was cumbersome and time-consuming. To address this, a custom-made sterile work 'Freedom EVO System' equipped with an 84-plate LiCONiC incubator was introduced. [Case Study] - Installation Site: Australian Centre for Eye Research (CERA) - Purpose of Installation: To free staff from simple tasks and minimize variability in cultured cells - Product Installed: 'Freedom EVO System' *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Benefits of Introduction】 ■ Enables the supply of a large number of cells for research purposes ■ The quantity of iPS cell lines produced within a few months after introduction exceeds that of the previous several years *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs![[FreedomEVO Case Study] Australia Eye Research Center](https://image.mono.ipros.com/public/catalog/image_generated/01/5ad/404558/404558_IPROS8412231924667015443_1.jpg?w=120&h=170)
Company information
Tecan is a company that was established in Switzerland in 1980, specializing in the manufacturing and development of life science research support equipment. With the support of many customers, we were able to celebrate our 30th anniversary in Japan in 2022. Tecan Japan operates two businesses. One is the life sciences business, which delivers Tecan-branded products such as automated pipetting systems and microplate readers to end-users. The other is the partnering business, which provides components and equipment as OEM products for partner companies. Our customers span a wide range of fields, including disease research, drug discovery, biotechnology, clinical testing (such as cancer diagnosis, infectious disease diagnosis, and testing centers), scientific analysis, and robotic surgery. Our mission is to improve people's lives and health. Tecan Japan aims to contribute to global health care innovation from the life sciences industry to clinics by supporting our customers' daily activities.
